Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
36.70
+3.47 (10.44%)
At close: Apr 24, 2025, 4:00 PM
36.70
0.00 (0.00%)
After-hours: Apr 24, 2025, 7:50 PM EDT

Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $27.07 billion. The enterprise value is $26.67 billion.

Market Cap 27.07B
Enterprise Value 26.67B

Important Dates

The next estimated earnings date is Monday, May 5, 2025, before market open.

Earnings Date May 5, 2025
Ex-Dividend Date n/a

Share Statistics

SMMT has 737.68 million shares outstanding. The number of shares has increased by 15.96% in one year.

Current Share Class 737.68M
Shares Outstanding 737.68M
Shares Change (YoY) +15.96%
Shares Change (QoQ) +1.49%
Owned by Insiders (%) 80.65%
Owned by Institutions (%) 12.68%
Float 111.19M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 69.64
P/TBV Ratio 69.98
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.15, with a Debt / Equity ratio of 0.02.

Current Ratio 10.15
Quick Ratio 9.89
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -24.29

Financial Efficiency

Return on equity (ROE) is -94.90% and return on invested capital (ROIC) is -45.49%.

Return on Equity (ROE) -94.90%
Return on Assets (ROA) -41.31%
Return on Invested Capital (ROIC) -45.49%
Return on Capital Employed (ROCE) -53.57%
Revenue Per Employee n/a
Profits Per Employee -$1.39M
Employee Count 159
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +883.91% in the last 52 weeks. The beta is -0.46, so SMMT's price volatility has been lower than the market average.

Beta (5Y) -0.46
52-Week Price Change +883.91%
50-Day Moving Average 20.97
200-Day Moving Average 18.47
Relative Strength Index (RSI) 78.99
Average Volume (20 Days) 4,775,461

Short Selling Information

Short Interest 23.77M
Short Previous Month 21.22M
Short % of Shares Out 19.96%
Short % of Float n/a
Short Ratio (days to cover) 10.06

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -210.99M
Pretax Income -161.69M
Net Income -221.32M
EBITDA -210.90M
EBIT -210.99M
Earnings Per Share (EPS) -$0.31
Full Income Statement

Balance Sheet

The company has $412.35 million in cash and $7.22 million in debt, giving a net cash position of $405.13 million or $0.55 per share.

Cash & Cash Equivalents 412.35M
Total Debt 7.22M
Net Cash 405.13M
Net Cash Per Share $0.55
Equity (Book Value) 388.75M
Book Value Per Share 0.53
Working Capital 382.02M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$142.11 million and capital expenditures -$139,000, giving a free cash flow of -$142.25 million.

Operating Cash Flow -142.11M
Capital Expenditures -139,000
Free Cash Flow -142.25M
FCF Per Share -$0.19
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -15.96%
Shareholder Yield -15.96%
Earnings Yield -0.82%
FCF Yield -0.53%
Dividend Details

Analyst Forecast

The average price target for SMMT is $35.44, which is -3.43% lower than the current price. The consensus rating is "Strong Buy".

Price Target $35.44
Price Target Difference -3.43%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2